SLC30A8 and type 2 diabetes mellitus: Furthermore, the carriers of protein-truncating variants in SLC30A8 have been reported to exhibit a 65% lower risk of T2D compared to non-carriers, indicating that the gene’s loss of function protects against diabetes [9].